Advertisements


Metformin HCl/[email protected]
Price: | US$ 1 / Gram |
---|---|
Minimum Order: | 10gram |
Payment Terms: | Western Union,Money Gram,Bank Transfer,Bitcoin |
Port of Export: | hong kong /china |
Product Details
Model No.: | CAS NO.:1115-70-4 | Brand Name: | YC |
---|
Certification: | ISO 9001 |
---|---|
Specification: |
Product Name:Metformin Hydrochloride,Dimethylbiguanide Hydrochloride
CAS NO.:1115-70-4 EINECS:214-230-6 Molecular Formula:C4H12ClN5 Molecular Weight:165.62 Appearance:White crystals or white crystalline powder |
Packaging & Delivery
Packaging: | As Requires |
---|---|
Delivery/Lead Time: | Within 3-7 working days |
Production Capacity: | 5000kg/Month |
Product Description
Product Name:Metformin Hydrochloride,Dimethylbiguanide Hydrochloride
CAS NO.:1115-70-4
EINECS:214-230-6
Molecular Formula:C4H12ClN5
Molecular Weight:165.62
Appearance:White crystals or white crystalline powder
Metformin, marketed under the tradename Glucophage among others, is an antidiabetic medication which is taken by mouth. It is the first-line drug of choice for the treatment of type 2 diabetes, in particular, in overweight and obese people and those with normal kidney function.Its use in gestational diabetes has been limited by safety concerns. It is also used in the treatment of polycystic ovary syndrome, and has been investigated for other diseases where insulin resistance may be an important factor. Metformin works by suppressing glucose production by the liver.
Limited evidence suggests metformin may prevent the cardiovascular and possibly the cancer complications of diabetes.It helps reduce LDL cholesterol and triglyceride levels and is not associated with weight gain; in some people, it promotes weight loss.Metformin is one of only two oral antidiabetics in the World Health Organization Model List of Essential Medicines (the other being glibenclamide)
Metformin is primarily used for type 2 diabetes, but is increasingly being used in polycystic ovary syndrome,non-alcoholic fatty liver disease (NAFLD)and premature puberty,three other diseases that feature insulin resistance; these indications are still considered experimental. The benefit of metformin in NAFLD has not been extensively studied and may be only temporary;although some randomized controlled trials have found significant improvement with its use, the evidence is still insufficient.
SUPPLIER PROFILE
|
|||
---|---|---|---|
Company: | Wuhan Hengwo Techenology co.,Ltd | ||
City/State | Wuhan, Hubei | Country: |
China ![]() |
Business Type: | Export - Manufacturer / Trading Company | Established: | NA |
Member Since: | 2017 | Contact Person | Jerry Jiang |
SUPPLIER PROFILE
City/State/Country -
Wuhan, Hubei
China 

Business Type -
Export - Manufacturer / Trading Company
Established -
NA
Member Since -
2017
Contact Person -
Jerry Jiang